Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 9/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 5/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17940700 | 0.90 | HCAR1 (0.43) | KMT2AALDH1A1HTTGFERHPGD | |
| SCHEMBL17940717 | 0.83 | FGFR1 (0.61) | ALDH1A1HTTGFERFGFR1GABRA1 | |
| SCHEMBL17940768 | 0.82 | HPGD (0.53) | KMT2AALDH1A1HPGDFGFR1GABRA1 | |
| SCHEMBL17940747 | 0.80 | HPGD (0.48) | KMT2AALDH1A1HPGDFGFR1GABRA1 | |
| SCHEMBL32675842 | 0.76 | GABRA1 (0.44) | ALDH1A1HTTGFERHPGDFGFR1 | |
| SCHEMBL17940785 | 0.75 | PRKCI (0.49) | ALDH1A1HTTHPGDFGFR1GABRA1 | |
| SCHEMBL16147463 | 0.74 | FGFR1 (0.68) | ALDH1A1HTTHPGDFGFR1 | |
| SCHEMBL29829658 | 0.74 | FGFR1 (0.68) | ALDH1A1HTTHPGDFGFR1 | |
| SCHEMBL17947696 | 0.73 | KMT2A (0.43) | KMT2AALDH1A1HTTHPGDGABRA1 | |
| SCHEMBL30269609 | 0.72 | HPGD (0.48) | KMT2AALDH1A1HPGDFGFR1GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114933614-A | Organic electroluminescent material and device | 环球展览公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-105820122-B | Organic electroluminescent material and device | 环球展览公司 | 2022-05-17 | — | — | CN | disclosed |
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | KMT2A 3749/4885ALDH1A1 1620/4885HTT 2766/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | KMT2A 3749/4885ALDH1A1 1620/4885HTT 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.